|
EP3771466A1
|
|
Membrane filtration of plant extracts using cyclodextrin
|
|
EP3689358A1
|
|
Method for the preparation of plant materials with reduced variance
|
|
EP3498306A1
|
|
Extracts from vitex agnus castus for the treatment and diagnosis of breast cancer
|
|
RU2715230C2
|
|
Method of treating oropharyngeal candidiasis in hiv-infected patients in advanced stages of disease
|
|
EA033235B1
|
|
Canephron for treatment of prostatitis
|
|
EP2959910A1
|
|
Milk thistle extract of fruit shells of Silybum marianum, process of manufacture and use
|
|
EP2810650A1
|
|
Medicament comprising thyme and primrose or thyme and ivy as PDE-4 inhibitor
|
|
CN106421162A
|
|
Method for producing dry extracts
|
|
WO2013007807A1
|
|
Selected cimicifuga fractions for the treatment of osteoporosis
|
|
EP2620155A1
|
|
Medicine containing Cimicifuga for use in the treatment of sarcopenia and myocardial weakness
|
|
EP2606902A1
|
|
Rhus copallina extract as medicine
|
|
EP2559438A1
|
|
Method for manufacturing dry extracts
|
|
EP2545932A1
|
|
Selected cimicifuga fractions for treating osteoporosis
|
|
WO2011144639A1
|
|
Extract of parts of sambucus for use in the treatment of inflammatory processes, intimal hyperplasia and vein graft disease
|
|
WO2011134667A2
|
|
Selected plant extract hydrolysates, and antibacterial agent containing the same
|
|
DE102010040705A1
|
|
Flower extract of Primula flos for the treatment and prophylaxis of inflammation or viral infections
|
|
DE102010021842A1
|
|
Thyme / primrose or ivy for the treatment of chronic obstructive pulmonary disease (COPD)
|
|
DE102010019099A1
|
|
Selected plant extracts for the treatment of inflammatory diseases
|
|
DE102009050407A1
|
|
Anti-inflammatory agent containing hydrolysates from plant extracts
|
|
DE102009041753A1
|
|
Detergents, cleaners or disinfectants containing hydrolysates from plant extracts
|
